Allometric scaling of therapeutic monoclonal antibodies in preclinical and clinical settings

Constant technological advancement enabled the production of therapeutic monoclonal antibodies (mAbs) and will continue to contribute to their rapid expansion. Compared to small-molecule drugs, mAbs have favorable characteristics, but also more complex pharmacokinetics (PK), e.g., target-mediated no...

Full description

Bibliographic Details
Published in:mAbs
Main Authors: Eva Germovsek, Ming Cheng, Craig Giragossian
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19420862.2021.1964935